Lisata Therapeutics
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $70 | $0 | $1,000 | $0 |
Gross Profit | 26 | -43 | 1,000 | -41 |
EBITDA | -4,615 | -5,643 | -4,569 | -5,294 |
EBIT | -4,659 | -5,686 | -4,610 | -5,336 |
Net Income | -4,659 | -4,724 | -4,610 | -4,930 |
Net Change In Cash | 70 | 0 | 1,000 | 0 |
Free Cash Flow | -3,956 | -5,402 | -4,528 | -2,518 |
Cash | 16,835 | 20,217 | 16,209 | 19,509 |
Basic Shares | 8,605 | 8,602 | 8,329 | 8,321 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $1,000 | $0 | $121,372 | $0 |
Gross Profit | 1,000 | -189 | 63,771 | -55 |
EBITDA | -22,235 | -25,519 | -56,635 | -28,995 |
EBIT | -22,409 | -25,708 | -56,704 | -29,050 |
Net Income | -19,985 | -20,840 | -54,225 | -27,466 |
Net Change In Cash | 1,000 | 0 | 121,372 | 0 |
Free Cash Flow | -19,356 | -20,032 | -21,455 | -22,305 |
Cash | 16,209 | 22,593 | 32,154 | 24,647 |
Basic Shares | 8,329 | 8,073 | 5,180 | 3,688 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | -$0.54 |
2025-03-31 | -$0.55 |
2024-12-31 | -$0.55 |
